| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 |
|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||
Net loss | ||||||
-2,578 | -441 | -12,061 | 355 | -1,774 | 4,079 | -3 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Income earned on investments held in Trust Account | ||||||
- | 1,032 | 1,314 | 1,493 | 1,400 | 1,125 | 0 |
Change in fair value of warrant liability | ||||||
2,800 | 1,096 | 12,903 | 598 | 2,801 | -3,448 | 0 |
Formation and operating costs paid by Sponsor in exchange for issuance of common stock | ||||||
- | - | - | - | - | - | 8 |
Changes in operating assets and liabilities: | ||||||
Prepaid expenses | ||||||
63 | -76 | -84 | 61 | 28 | 101 | 0 |
Accounts payable | ||||||
149 | -6 | 21 | -121 | 24 | 59 | 2 |
Accrued expenses | ||||||
141 | -38 | 38 | -9 | -5 | 15 | 0 |
Franchise tax payable | ||||||
-149 | 50 | 50 | 50 | -53 | 103 | 0 |
Income tax payable | ||||||
151 | 155 | 0 | -507 | 292 | 214 | 0 |
Net cash used in operating activities | ||||||
-321 | -173 | -254 | -1,189 | -165 | -194 | -1 |
Cash Flows from Investing Activities | ||||||
Investment income released from Trust Account to pay franchsie and income taxes | ||||||
200 | 0 | 194 | 947 | 0 | - | 0 |
Payment of offering costs | ||||||
0 | - | - | - | 100 | - | - |
Net cash provided by (used in) investing activities | ||||||
200 | 0 | 194 | 1,047 | -100 | -243,765 | 0 |
Cash Flows from Financing Activities: | ||||||
Proceeds from note payable from related parties | ||||||
- | - | - | - | - | 0 | 130 |
Payment of offering costs | ||||||
- | - | - | - | - | 5,328 | 109 |
Net cash provided by (used in) financing activities | ||||||
- | - | - | - | - | 245,381 | 20 |
Net decrease in cash | ||||||
-121 | -173 | -59 | -242 | -266 | 1,421 | 19 |
Supplemental disclosure of noncash activities: | ||||||
Change in value of common stock subject to possible redemption | ||||||
31,935 | -441 | -12,061 | -3,225 | 1,790 | 225,767 | 0 |
Deferred offering costs paid by Sponsor in exchange for issuance of common stock | ||||||
- | - | - | - | - | 0 | 16 |
Deferred offering costs included in accounts payable | ||||||
- | - | - | - | - | 47 | 0 |
Deferred offering costs included in accrued expenses | ||||||
- | - | - | - | - | -18 | 103 |
Supplemental cash flow disclosure: | ||||||
Cash paid for income taxes | ||||||
- | - | - | - | - | - | 0 |